AnalystsLeonid TimashevLeonid Timashev's Stock Forecasts
AnalystsLeonid Timashev
Analyst Ranking
Top 9%
#453 out of 5235 analysts
Average Return
+12.26%
Win Rate
52%74 out of 143
Risk vs Reward
Poor
Good
Leonid Timashev's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Newamsterdam Pharma Co NvNAMS | +164.57% | $7.17 | $18.97 | 2023-10-29 - 2024-10-29 | Buy |
Edgewise Therapeutics IncEWTX | +162.85% | $12.68 | $33.33 | 2025-08-07 - 2026-04-02 | Buy |
Cg Oncology IncCGON | +158.74% | $26.08 | $67.48 | 2025-07-15 - 2026-04-02 | Buy |
Nuvation Bio IncNUVB | +157.89% | $1.71 | $4.41 | 2025-06-16 - 2026-04-02 | Buy |
Edgewise Therapeutics IncEWTX | +145.43% | $13.58 | $33.33 | 2025-04-02 - 2026-04-02 | Buy |
Leonid Timashev Analyst Color
Get additional color on Leonid Timashev's coverage of popular stocks
Leonid Timashev's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bicycle Therapeutics PLCBCYC | 3 | Hold | $7.00 | +38.61% | Maintains | 18 days ago |
Perspective Therapeutics IncCATX | 2 | Buy | $14.00 | +217.46% | Maintains | 19 days ago |
Legend Biotech CorpLEGN | 15 | Buy | $62.00 | +223.93% | Maintains | 25 days ago |
Design Therapeutics IncDSGN | 11 | Buy | $14.00 | +24.67% | Maintains | a month ago |
Nuvation Bio IncNUVB | 5 | Buy | $13.00 | +194.78% | Maintains | a month ago |
Biohaven LtdBHVN | 15 | Buy | $23.00 | +134.69% | Maintains | a month ago |
Exelixis IncEXEL | 4 | Hold | $43.00 | -2.01% | Maintains | a month ago |
Beone Medicines LtdONC | 6 | Buy | $425.00 | +36.75% | Maintains | a month ago |
Alkermes PLCALKS | 6 | Buy | $45.00 | +29.16% | Maintains | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 4 | Buy | $195.00 | +4.31% | Maintains | a month ago |
Axsome Therapeutics IncAXSM | 16 | Buy | $222.00 | +31.75% | Maintains | a month ago |
Cytokinetics IncCYTK | 7 | Buy | $101.00 | +51.36% | Maintains | a month ago |
Ideaya Biosciences IncIDYA | 5 | Buy | $49.00 | +49.66% | Reiterates | 2 months ago |
Compass Pathways PLCCMPS | 6 | Buy | $22.00 | +279.97% | Maintains | 2 months ago |
Cg Oncology IncCGON | 3 | Buy | $73.00 | +8.18% | Maintains | 2 months ago |
Newamsterdam Pharma Co NvNAMS | 9 | Buy | $47.00 | +42.47% | Maintains | 2 months ago |
Cormedix IncCRMD | 3 | Buy | $13.00 | +84.40% | Maintains | 2 months ago |
Revolution Medicines IncRVMD | 2 | Buy | $140.00 | +41.24% | Maintains | 2 months ago |
Insmed IncINSM | 8 | Buy | $200.00 | +23.13% | Maintains | 2 months ago |
Pyxis Oncology IncPYXS | 7 | Buy | $5.00 | +237.84% | Maintains | 4 months ago |
Jasper Therapeutics IncJSPR | 1 | Hold | $4.00 | +481.40% | Maintains | 5 months ago |
Edgewise Therapeutics IncEWTX | 15 | Buy | $50.00 | +50.02% | Maintains | 5 months ago |
Xencor IncXNCR | 3 | Buy | $19.00 | +48.32% | Maintains | 5 months ago |
Verastem IncVSTM | 2 | Buy | $13.00 | +130.91% | Maintains | 8 months ago |
Adc Therapeutics SaADCT | 1 | Buy | $5.00 | +32.28% | Maintains | 10 months ago |
Brc IncBRCC | 1 | Strong Buy | $3.00 | N/A | Maintains | a year ago |
Incyte CorpINCY | 1 | Hold | $70.00 | N/A | Reiterates | a year ago |
Neubase Therapeutics IncNBSE | 1 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.